Paper32632160
An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment.
GeurtsvanKessel CH and 15 others. Nat Commun, 2020. Cited by 292 papers, by iCite.
Cite this record
ConductScience Library. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Papers, record 32632160. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32632160
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| Coronavirus Infections | Major topic |
| Pneumonia, Viral | Major topic |
| Serologic Tests | Major topic |
| Antibodies, Neutralizing | |
| Betacoronavirus | |
| COVID-19 | |
| COVID-19 Testing | |
| Clinical Laboratory Techniques | |
| Enzyme-Linked Immunosorbent Assay | |
| High-Throughput Screening Assays | |
| Humans | |
| Luminescent Measurements | |
| Neutralization Tests | |
| Pandemics | |
| SARS-CoV-2 | |
| Sensitivity and Specificity |
Source PubMed
Cited by242
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 292 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42163160 | SARS-CoV-2 seroprevalence among pregnant women during the first three waves of the COVID-19 pandemic in southern Mozambique. | BMC Pregnancy Childbirth | 2026 | https://conductscience.org/library/papers/42163160 | PubMed |
| 41947067 | Optimising COVID-19 episode identification using serology and PCR/rapid antigen testing: insights from the BRACE trial. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/41947067 | PubMed |
| 41787546 | Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020 - January 2021, Belgium. | Arch Public Health | 2026 | https://conductscience.org/library/papers/41787546 | PubMed |
| 41668864 | Molecular and seroepidemiology of SARS-CoV-2 among influenza-like illness and severe Acute respiratory illness cases in selected health facilities in Ethiopia. | Front Public Health | 2025 | https://conductscience.org/library/papers/41668864 | PubMed |
| 41315372 | Household exposure, demographic and health characteristics associated with SARS-CoV-2 infection in a cohort study in Northern France. | Sci Rep | 2025 | https://conductscience.org/library/papers/41315372 | PubMed |
| 40454936 | Comparison of NADAL COVID IgG/IgM rapid test and DiaSorin Liaison SARS-CoV-2 S1/S2 IgG assay across different blood sources and substrates. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/40454936 | PubMed |
| 40303713 | The Luciferase Immunoprecipitation System (LIPS) Targeting the Spike Protein of SARS-CoV-2 Is More Accurate than Nucleoprotein-Based LIPS and ELISAs for Mink Serology. | Transbound Emerg Dis | 2023 | https://conductscience.org/library/papers/40303713 | PubMed |
| 40284930 | Evaluation of SARS-CoV-2 Seroprevalence and Variant Distribution During the Delta-Omicron Transmission Waves in Greater Accra, Ghana, 2021. | Viruses | 2025 | https://conductscience.org/library/papers/40284930 | PubMed |
| 40263514 | Comparative evaluation of in-house ELISA and two commercial serological assays for the detection of antibodies against SARS-CoV-2. | Sci Rep | 2025 | https://conductscience.org/library/papers/40263514 | PubMed |
| 40196112 | A bivalent mRNA vaccine against RSV infection in rodent models. | Front Immunol | 2025 | https://conductscience.org/library/papers/40196112 | PubMed |
| 39844374 | SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022. | Epidemiol Infect | 2025 | https://conductscience.org/library/papers/39844374 | PubMed |
| 39730470 | Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico. | Sci Rep | 2024 | https://conductscience.org/library/papers/39730470 | PubMed |
| 39570844 | Serological survey in a university community after the fourth wave of COVID-19 in Senegal. | PLoS One | 2024 | https://conductscience.org/library/papers/39570844 | PubMed |
| 39378229 | Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study. | PLoS One | 2024 | https://conductscience.org/library/papers/39378229 | PubMed |
| 39063546 | Anti-SARS-CoV-2 Neutralizing Responses in Various Populations: Use of a Rapid Surrogate Lateral Flow Assay and Correlations with Anti-RBD Antibody Levels. | Life (Basel) | 2024 | https://conductscience.org/library/papers/39063546 | PubMed |
| 38664455 | Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model. | Sci Rep | 2024 | https://conductscience.org/library/papers/38664455 | PubMed |
| 38620937 | Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort. | Clin Immunol Commun | 2021 | https://conductscience.org/library/papers/38620937 | PubMed |
| 38427100 | Quantification of SARS-CoV-2 monoclonal IgG mass fraction by isotope dilution mass spectrometry. | Anal Bioanal Chem | 2024 | https://conductscience.org/library/papers/38427100 | PubMed |
| 38228735 | Multicentric evaluation of sensitivity of eight commercial anti-SARS-CoV-2 antibody assays and their correlation to virus neutralization titers in seropositive subjects. | Sci Rep | 2024 | https://conductscience.org/library/papers/38228735 | PubMed |
| 38107343 | Comparative analysis of SARS-CoV-2 detection methods using stool, blood, and nasopharyngeal swab samples. | Pan Afr Med J | 2023 | https://conductscience.org/library/papers/38107343 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 | NCBI Gene |
| PRNT | 149830 | PubTator's text mining | https://conductscience.org/library/genes/149830 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32632160
GET https://conductscience.org/api/papers/v1/32632160/cited_by?page=2